Finance

Therapeutics company announces private placement financing

Published in Drug Week, September 2nd, 2005

Pharmacopeia (PCOP) announced that it has sold 2,470,000 shares of newly issued common stock at a price of $3.43 per share to certain institutional investors for aggregate proceeds of approximately $8.47 million, before placement fees and other offering expenses.

The offering price of $3.43 was determined by applying a 15% discount to the 5-day trailing average closing price of Pharmacopeia common stock of $4.04.

Jefferies & Company, Inc., acted as financial advisor and sole placement agent to Pharmacopeia for the transaction.

The securities sold in this private placement have not been registered under the Securities Act of 1933,...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Drug Week

Source: Drug Week (2005-09-02)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry